10 May 23
tranScrip has extensive expertise in the infectious diseases area, including antibacterials, antifungals and antivirals. tranScrip has supported pharma and biotech companies across all phases of preclinical and clinical development, including microbiology, PK/PD, design and oversight of clinical programmes, regulatory strategies and agency interactions, MAA/ NDA submissions, peri-launch medical affairs and commercial activities, as well as in-licensing, fund-raising and due diligence activities.
Click here to read the full brochure.
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.